185 related articles for article (PubMed ID: 29704059)
1. Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study.
Zaffuto E; Bandini M; Gazdovich S; Valiquette AS; Leyh-Bannurah SR; Tian Z; Dell'Oglio P; Graefen M; Moschini M; Necchi A; Shariat SF; Briganti A; Montorsi F; Karakiewicz PI
World J Urol; 2018 Sep; 36(9):1417-1422. PubMed ID: 29704059
[TBL] [Abstract][Full Text] [Related]
2. Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.
Hermans TJ; Fransen van de Putte EE; Fossion LM; Werkhoven EV; Verhoeven RH; van Rhijn BW; Horenblas S
Urol Oncol; 2016 Dec; 34(12):532.e7-532.e12. PubMed ID: 27491835
[TBL] [Abstract][Full Text] [Related]
3. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
4. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
Leyh-Bannurah SR; Budäus L; Zaffuto E; Pompe RS; Bandini M; Briganti A; Montorsi F; Schiffmann J; Shariat SF; Fisch M; Chun F; Huland H; Graefen M; Karakiewicz PI
Urol Oncol; 2018 Feb; 36(2):81.e17-81.e24. PubMed ID: 29248430
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
[TBL] [Abstract][Full Text] [Related]
6. Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.
Mistretta FA; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Cancer Epidemiol; 2019 Apr; 59():135-142. PubMed ID: 30771698
[TBL] [Abstract][Full Text] [Related]
7. [Effects of performing pelvic lymph node dissection before versus after radical cystectomy].
Zhu ZS; Ye M; Shi HQ; Zhou YB; Chen LY; Liu QQ; Zhang CT; Lou RL; Xu LZ
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(32):2574-7. PubMed ID: 24351600
[TBL] [Abstract][Full Text] [Related]
8. Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.
Schiffmann J; Haese A; Leyh-Bannurah SR; Salomon G; Steuber T; Schlomm T; Boehm K; Beyer B; Larcher A; Michl U; Heinzer H; Huland H; Graefen M; Karakiewicz PI
Eur J Surg Oncol; 2015 Nov; 41(11):1547-53. PubMed ID: 26117216
[TBL] [Abstract][Full Text] [Related]
9. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.
Bochner BH; Dalbagni G; Sjoberg DD; Silberstein J; Keren Paz GE; Donat SM; Coleman JA; Mathew S; Vickers A; Schnorr GC; Feuerstein MA; Rapkin B; Parra RO; Herr HW; Laudone VP
Eur Urol; 2015 Jun; 67(6):1042-1050. PubMed ID: 25496767
[TBL] [Abstract][Full Text] [Related]
10. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
Fang AC; Ahmad AE; Whitson JM; Ferrell LD; Carroll PR; Konety BR
Cancer; 2010 Apr; 116(8):1901-8. PubMed ID: 20186823
[TBL] [Abstract][Full Text] [Related]
11. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
Kosiba M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2022 Apr; 20(2):195.e1-195.e8. PubMed ID: 34906434
[TBL] [Abstract][Full Text] [Related]
13. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
14. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder.
Grabbert M; Grimm T; Buchner A; Kretschmer A; Apfelbeck M; Schulz G; Jokisch F; Schneevoigt BS; Stief CG; Karl A
Int Urol Nephrol; 2017 Dec; 49(12):2137-2142. PubMed ID: 28900840
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of guideline adherence for pelvic lymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer.
Borkowetz A; Bruendl J; Drerup M; Herrmann J; Isbarn H; Beyer B;
World J Urol; 2018 Jun; 36(6):855-861. PubMed ID: 29427005
[TBL] [Abstract][Full Text] [Related]
17. Determinants of adequate lymph node dissection following neoadjuvant chemotherapy in patients with urothelial muscle-invasive bladder cancer: results from the National Cancer Database.
Monaghan TF; Flores VX; Suss NR; Robins DJ; Smith MT; McNeil BK; Hyacinthe LM; Weiss JP; Winer AG
Int Urol Nephrol; 2021 Feb; 53(2):235-239. PubMed ID: 32865771
[TBL] [Abstract][Full Text] [Related]
18. Trends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder.
Klose C; Gordon O; Sparks A; Whalen M
Clin Genitourin Cancer; 2023 Dec; 21(6):703-709. PubMed ID: 37336704
[TBL] [Abstract][Full Text] [Related]
19. Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes.
Desai MM; Berger AK; Brandina RR; Zehnder P; Simmons M; Aron M; Skinner EC; Gill IS
Eur Urol; 2012 Feb; 61(2):350-5. PubMed ID: 22036642
[TBL] [Abstract][Full Text] [Related]
20. Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template.
Fransen van de Putte EE; Hermans TJ; Werkhoven Ev; Mertens LS; Meijer RP; Bex A; Wassenaar AE; van der Poel HG; van Rhijn BW; Horenblas S
Urol Oncol; 2015 Dec; 33(12):504.e19-24. PubMed ID: 26329817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
